Abemaciclib,Anastrozole,Letrozole
Eli Lilly,Novartis
[]
 was the control arm undertreated? why only 31% of patients in this arm received cdk4/6-i at progression?
MD de la UN. Especialista en medicina interna, docencia y oncología.